paramyxovirus
enter
cell
direct
fusion
viral
envelop
plasma
membran
previou
studi
shown
coloc
newcastl
diseas
viru
ndv
earli
endosom
marker
inhibit
ndv
fusion
caveolinphosphoryl
drug
phorbol
pma
prompt
us
propos
ndv
enter
cell
via
endocytosi
show
viruscel
fusion
cellcel
fusion
promot
ndvf
increas
brief
exposur
low
ph
hela
cell
ndv
receptordefici
cell
line
brief
lowph
exposur
percentag
ndv
fusion
similar
without
acidph
stimul
mean
acid
ph
would
decreas
energet
barrier
enhanc
fusion
furthermor
preincub
cell
protein
kinas
c
inhibitor
bisindolylmaleimid
led
inhibit
ndv
infect
suggest
popul
viru
enter
cell
receptormedi
endocytosi
moreov
involv
gtpase
dynamin
ndv
entri
shown
specif
inhibitor
dynasor
also
impair
ndv
fusion
infect
optim
infect
host
cell
significantli
affect
drug
inhibit
endosom
acidif
concanamycin
monensin
chloroquin
result
support
hypothesi
entri
ndv
hela
cell
occur
plasma
membran
well
dynaminlow
phand
receptordepend
endocytosi
newcastl
diseas
viru
ndv
prototyp
paramyxoviru
avian
envelop
rnaneg
strand
viru
caus
respiratori
diseas
domest
fowl
lead
huge
econom
loss
poultri
industri
envelop
ndv
contain
two
associ
glycoprotein
mediat
viral
entri
hemagglutininneuraminidas
hn
fusion
f
protein
hn
receptorbind
protein
recogn
bind
sialoglycoconjug
cell
surfac
also
receptorcleav
sialidas
activ
base
crystallograph
studi
hn
ndv
two
sialic
acidbind
site
describ
site
ii
locat
dimer
interfac
activ
engag
site
receptor
site
exhibit
receptorbind
sialidas
activ
site
ii
receptor
bind
activ
moreov
trigger
f
protein
requir
presenc
homotyp
attach
protein
fusion
promot
activ
envelop
virus
enter
cell
two
main
mechan
direct
fusion
viral
envelop
plasma
membran
endocytosi
use
cellular
endocyt
machineri
commonli
associ
lowphdepend
activ
viral
fusion
protein
influenza
viru
vesicular
stomat
viru
addit
fusion
protein
ebola
viru
activ
acidicphdepend
proteas
insid
endosom
moreov
recent
studi
suggest
virus
phindepend
fusion
protein
may
use
endocytosi
entri
revis
differ
famili
virus
may
use
sever
differ
endocyt
rout
major
pathway
clathrinmedi
endocytosi
use
virus
semliki
forest
sindbi
alpha
viru
hantaan
viru
recent
report
indic
hiv
also
use
rout
product
caveolamedi
endocytosi
second
best
character
pathway
use
ebola
virus
enter
cell
although
virus
describ
enter
cell
uniqu
mechan
increas
report
show
mani
virus
abl
use
altern
uptak
pathway
infect
differ
target
cell
even
simultan
entri
mechan
cell
type
refer
therein
except
fusion
protein
human
metapneumoviru
hmpv
depend
lowph
paramyxoviru
fusion
protein
activ
neutral
ph
suggest
viral
entri
occur
direct
fusion
plasma
membran
nevertheless
recent
report
point
notion
ph
requir
fusion
necessarili
impli
locat
membran
fusion
revis
member
paramyxovirus
sendai
nipah
human
metapneumoviru
human
respiratori
syncyti
viru
hrsv
util
endocyt
machineri
entri
furthermor
assess
dequench
assay
previou
studi
reveal
enhanc
ndv
fusion
acid
ph
coloc
ndv
earli
endosom
marker
find
prompt
us
suggest
entri
ndv
would
occur
caveolamedi
endocytosi
addit
mechan
direct
fusion
plasma
membran
gain
insight
molecular
mechan
ndv
entri
present
studi
focus
character
ndv
entri
mechan
use
lowph
treatment
sever
cell
line
differ
express
sialoglycoconjug
surfac
analyz
effect
differ
substanc
either
interfer
endocytosi
endosom
acidif
ndv
interact
cell
ndv
entri
show
sensit
endosom
acid
ph
dynamin
protein
kinas
c
inhibitor
block
ndv
fusion
infect
data
support
idea
ndv
may
penetr
hela
cell
direct
fusion
cell
surfac
receptormedi
dynamindepend
endocytosi
least
cell
line
east
lans
line
avian
fibroblast
hela
cell
obtain
american
type
cultur
collect
atcc
obtain
riken
brc
cell
bank
tsukuba
japan
hela
cell
maintain
dulbecco
modifi
eagl
medium
dmem
chines
hamster
ovari
cho
mutant
also
purchas
atcc
maintain
dmem
alphamem
media
respect
media
supplement
lglutamax
mg
l
invitrogen
penicillinstreptomycin
u
ml
ml
heatinactiv
fetal
bovin
serum
complet
medium
lentogen
clone
strain
ndv
obtain
intervet
laboratori
salamanca
spain
viru
grown
purifi
mainli
describ
previous
inect
assay
recombin
ndv
deriv
hitchner
lentogen
strain
express
monomer
redfluoresc
protein
kindli
provid
dr
adolfo
use
bisindolylmaleimid
bim
calbiochem
dynasor
concanamycin
monensin
chloroquin
proteas
inhibitor
cocktail
proteinas
k
sigma
chemic
co
octadecylrhodamin
b
chlorid
hoechst
calcein
lipofectamin
alexa
fluor
donkey
antimous
antibodi
molecular
probe
monoclon
antinp
polyclon
antindv
antibodi
gener
gift
dr
emerg
pathogen
institut
mount
sinai
school
medicin
new
york
usa
monoclon
antihn
antibodi
kindli
provid
dr
iorio
univers
massachusett
medic
school
worcest
usa
viru
titer
calcul
plaqueform
assay
vero
cell
describ
plaqu
number
count
light
microscop
ndv
infect
express
plaqueform
unit
pfu
ml
monolay
hela
cho
cell
mm
plate
previous
treat
differ
inhibitor
incub
ndv
moi
h
continu
presenc
inhibitor
cell
wash
icecold
pb
remov
unbound
viru
collect
plate
incub
edta
cell
pellet
centrifug
fix
paraformaldehyd
min
centrifug
cell
incub
antihn
mab
block
solut
dilut
h
cell
centrifug
incub
block
solut
contain
antimous
alexa
fluor
igg
ml
h
cell
pellet
centrifug
resuspend
suitabl
volum
pb
analysi
facscalibur
flow
cytomet
becton
dickinson
least
cell
analyz
sampl
mean
fluoresc
valu
normal
control
valu
data
analyz
winmdi
softwar
purifi
ndv
label
fluoresc
probe
essenti
describ
previous
cell
plate
plate
treat
untreat
inhibitor
incub
min
ice
per
plate
cell
wash
three
time
cold
pb
incub
complet
medium
contain
hoechst
ml
h
fix
formaldehyd
pb
transfer
rhodamin
probe
cell
observ
olympu
invert
fluoresc
microscop
percentag
fusion
calcul
number
posit
redstain
cell
random
field
respect
total
number
cell
area
well
monolay
cell
infect
h
room
temperatur
differ
dilut
recombin
ndv
h
cell
observ
olympu
invert
fluoresc
microscop
object
percentag
infect
calcul
number
redfluoresc
cell
total
number
cell
six
random
field
monolay
hela
cho
cell
mm
plate
treat
inhibitor
incub
moi
ndv
h
presenc
inhibitor
cell
wash
icecold
pb
remov
unbound
viru
collect
plate
incub
edta
cell
pellet
centrifug
fix
paraformaldehyd
min
cell
block
permeabil
pb
contain
bsa
block
solut
min
centrifug
cell
incub
antinp
mab
block
solut
dilut
h
centrifug
incub
block
solut
contain
antimous
alexa
fluor
igg
ml
h
cell
pellet
centrifug
resuspend
suitabl
volum
pb
analysi
facscalibur
flow
cytomet
becton
dickinson
least
cell
analyz
sampl
mean
fluoresc
valu
cell
fluoresc
higher
background
combin
quantifi
viral
protein
express
normal
control
valu
mean
fluoresc
valu
normal
control
valu
data
analyz
winmdi
softwar
monolay
cell
infect
moi
ndv
h
h
postinfect
viral
f
protein
activ
digest
acetyl
trypsin
cell
incub
complet
medium
overnight
stain
giemsa
crystal
violet
syncytium
observ
repres
field
captur
invert
microscop
olympu
quantif
syncytia
accomplish
measur
area
pixel
refer
total
area
field
three
random
field
area
quantifi
use
analysi
tool
adob
photoshop
cell
plate
plate
incub
min
ice
per
plate
viruscel
complex
expos
briefli
either
ph
ph
buffer
treat
puls
buffer
pb
h
regular
medium
neutral
ph
percentag
fusion
calcul
number
posit
redstain
cell
random
field
respect
total
number
cell
area
well
monolay
hela
cell
grown
plate
cotransfect
pcagg
encod
viral
f
protein
andor
hn
empti
pcagg
total
amount
dna
per
well
transfect
perform
use
lipofectamin
h
posttransfect
cell
wash
f
protein
activ
digest
acetyl
trypsin
describ
follow
dyetransf
fusion
syncytium
assay
perform
human
erythrocyt
rbc
doublelabel
calcein
octadecylrhodamin
b
chlorid
briefli
rbc
hematocrit
pb
incub
ml
aqueou
dye
calcein
h
dark
extens
wash
rbc
collect
centrifug
incub
stock
mg
ml
lipid
probe
min
room
temperatur
dark
follow
sever
wash
step
remov
unincorpor
dye
label
cell
monolay
hela
cell
plate
transfect
describ
h
posttransfect
f
protein
activ
describ
cell
expos
briefli
either
ph
ph
buffer
treat
min
puls
buffer
pb
media
remov
without
wash
cell
overlaid
dyehematocrit
per
well
dmem
effectortarget
cell
complex
incub
differ
temperatur
h
nuclei
stain
incub
ml
hoechst
dye
cell
wash
sever
time
pb
remov
unbound
rbc
dye
transfer
visual
invert
fluoresc
microscop
magnif
extent
fusion
calcul
percentag
dyelabel
cell
total
number
nuclei
confluent
monolay
cell
plate
pretreat
h
concanamycin
monensin
h
chloroquin
min
dynasor
inhibitor
vehicl
control
control
volum
equal
maximum
volum
drug
indic
concentr
tabl
infect
assay
infect
carri
averag
cell
would
infect
control
well
h
presenc
drug
vehicl
control
h
dynasor
experi
cell
wash
incub
regular
medium
overnight
bim
experi
cell
infect
presenc
inhibitor
h
room
temperatur
incub
h
dmem
drug
proteinas
k
treatment
cell
carri
previous
describ
viru
ad
cell
monolay
moi
viru
bind
perform
h
sampl
incub
differ
time
allow
entri
cell
treat
proteinas
k
ml
optimem
supplement
mm
cacl
h
proteasetr
cell
pellet
lyse
icecold
lysi
buffer
mm
trishcl
ph
mm
nacl
contain
mm
phenylmethylsulfonyl
fluorid
pmsf
cocktail
proteas
inhibitor
viral
protein
detect
western
blot
use
primari
rabbit
polyclon
antindv
antibodi
cell
detach
small
quantiti
mix
trypan
blue
pv
pb
pb
product
mix
min
transfer
counter
chamber
number
total
cell
stain
cell
dead
cell
count
percentag
viabil
calcul
number
viabl
cell
total
number
cell
twotail
unpair
student
ttest
use
determin
statist
signific
two
group
probabl
valu
p
b
consid
extrem
statist
signific
p
b
extrem
signific
p
b
statist
signific
statist
analys
perform
quickcalc
program
graphpad
softwar
paramyxovirus
enter
host
fusion
envelop
plasma
membran
neutral
ph
nevertheless
previous
report
enhanc
ndv
fusion
cell
acid
ph
investig
role
acid
ph
ndv
entri
analyz
ndv
fusion
differ
cell
line
short
puls
acid
ph
detail
materi
method
differ
target
cell
line
vari
surfac
glycoconjug
express
ie
ndv
receptor
hela
human
epitheli
cell
commonli
use
studi
mani
virus
includ
ndv
chicken
fibroblast
natur
host
ndv
glycosphingolipiddefici
cell
line
parent
cell
line
cho
mutant
cell
defici
complex
nlink
glycosyl
glycosphingolipid
oglycoprotein
analyz
viruscel
fusion
allow
bind
cell
min
viruscel
complex
expos
briefli
either
ph
ph
buffer
treatment
min
puls
buffer
pb
h
regular
medium
neutral
ph
percentag
fusion
calcul
number
posit
redstain
cell
total
number
cell
data
summar
fig
show
low
ph
puls
led
increas
fusion
two
cell
line
hela
suggest
enhanc
might
cell
typespecif
discuss
later
next
wish
determin
whether
syncytium
format
also
stimul
exposur
low
ph
virusinfect
hnf
transfect
cell
hela
cell
infect
ndv
moi
h
cell
treat
three
puls
min
ph
ph
pb
h
interv
puls
h
postinfect
syncytia
quantifi
fig
expect
syncytium
format
enhanc
time
compar
control
cell
line
data
correl
enhanc
viral
infect
observ
infect
recombin
ndv
fig
discuss
later
addit
determin
whether
hn
protein
essenti
fusion
acid
ph
treatment
hela
cell
transfect
f
andor
hn
vector
h
posttransfect
cell
treat
three
lowph
puls
cell
cotransfect
f
hn
plasmid
syncytium
format
increas
time
lowph
exposur
fig
comparison
control
acid
ph
treatment
increas
number
size
syncytia
micrograph
fig
nevertheless
ndv
f
protein
promot
format
syncytia
absenc
hn
treat
low
ph
fig
analyz
effect
acid
ph
exposur
ndv
infect
hela
cho
infect
recombin
ndv
h
room
temperatur
moi
except
hela
cell
infect
moi
hela
cell
becam
fulli
infect
moi
data
shown
cell
treat
three
puls
min
ph
ph
pb
h
interv
detail
materi
method
infect
monitor
h
postinfect
calcul
percentag
redfluoresc
infect
cell
total
number
cell
result
summar
fig
supplementari
fig
similar
fusion
fig
lowph
treatment
induc
enhanc
infect
exclus
hela
cell
support
idea
differ
entri
mechan
depend
cell
line
next
seri
experi
analyz
whether
acid
ph
treatment
abl
lower
temperatur
requir
ndv
f
proteininduc
fusion
order
determin
whether
possibl
effect
exert
differ
fusion
cascad
use
dyetransferbas
fusion
assay
detail
materi
method
hnand
ftransfect
cell
allow
fuse
rbc
doubli
label
red
probe
membran
green
probe
calcein
cytoplasm
proteolyt
activ
f
protein
cell
treat
puls
acid
neutral
ph
control
min
fluorescencelabel
erythrocyt
ad
allow
fuse
h
shown
fig
fusion
occur
either
neutral
ph
lowph
treatment
although
observ
increas
rbc
bind
transfect
cell
acid
ph
temperatur
fig
panel
supplementari
fig
might
contribut
enhanc
fusion
fusionpermiss
temperatur
nevertheless
suboptimum
temperatur
extent
fusion
treatment
ph
similar
fusion
neutral
ph
final
seen
fig
lowph
treatment
fusion
increas
case
transfer
two
probe
calceinwa
similar
indic
enhanc
fusion
due
puls
acid
ph
similar
effect
hemifus
transfer
membran
erythrocyt
membran
cell
complet
fusion
transfer
calcein
cytoplasm
erythrocyt
cytoplasm
cell
mention
data
support
hypothesi
acid
ph
would
decreas
energet
barrier
need
protein
activ
prior
trigger
fusion
although
hypothet
decreas
enough
allow
fusion
therefor
acid
ph
might
increas
number
f
protein
undergo
conform
chang
lead
membran
fusion
even
though
presenc
hn
protein
would
still
requir
enhanc
ndv
fusion
infect
exposur
acid
ph
report
fig
agreement
previou
result
strongli
support
role
low
ph
ndv
entri
notion
certain
percentag
ndv
may
enter
cell
endocytosi
least
certain
cell
line
hela
sinc
cours
infect
viru
would
encount
low
ph
endocytosi
traffick
endocyt
pathway
want
explor
possibl
endocyt
entri
ndv
studi
effect
differ
substanc
interfer
either
endocytosi
endosom
acidif
tabl
first
incub
target
cell
presenc
bisindolylmaleimid
bim
highli
select
cellperm
revers
protein
kinas
c
pkc
inhibitor
cell
cell
viabil
assay
trypan
blue
exclus
method
higher
except
strong
cytopath
effect
drug
observ
cell
death
data
shown
analyz
effect
bim
preincub
ndv
infect
three
differ
condit
drug
present
infect
withdrawn
cultur
medium
viru
bim
ii
drug
present
durat
assay
ie
infect
h
postinfect
viru
bimbim
iii
drug
ad
h
postinfect
virusbim
data
summar
fig
sinc
bim
per
se
compound
exhibit
red
fluoresc
background
fig
bim
subtract
red
fluoresc
due
mrfp
express
occur
infect
inhibitori
effect
bim
observ
drug
ad
postinfect
mean
must
act
earli
stage
infect
data
concern
inhibit
approxim
inhibit
compar
control
correl
well
observ
enhanc
viral
fusion
cell
line
lowph
exposur
shown
fig
infect
ndv
cell
also
reduc
bim
treatment
observ
reduct
could
due
neg
effect
drug
cell
viabil
accord
result
ndv
could
penetr
hela
cell
receptormedi
endocytosi
sinc
inhibit
pkc
reduc
ndv
infect
comparison
control
fig
similarli
activ
pkc
essenti
entri
differ
nonenvelop
envelop
virus
influenza
viru
alphaviru
rhabdoviru
poxviru
herp
viru
relat
entri
receptormedi
endocytosi
furthermor
previous
suggest
caveolaeraft
could
possibl
platform
ndv
entri
caveola
seem
major
cell
surfac
locat
pkc
also
analyz
effect
dynasor
drug
inhibit
gtpase
activ
dynamin
implic
clathrinand
caveolamedi
endocytosi
owe
high
toxic
drug
cho
cell
experi
perform
hela
cell
cell
viabil
higher
dynasor
treatment
data
shown
fusion
ndv
treatedhela
cell
almost
complet
abrog
fig
infect
assay
fluoresc
microscopi
infect
fig
fac
fig
nevertheless
bind
ndv
drugtreat
cell
modifi
data
shown
howev
addit
dynasor
min
postinfect
result
minor
decreas
infect
effect
ad
min
postinfect
fig
impli
main
role
dynamin
exert
earli
infect
step
support
role
endocytosi
ndv
entri
rate
fusion
infect
inhibit
exert
dynasor
higher
bim
fig
observ
enhanc
ndv
fusion
infect
lowph
exposur
fig
dynamin
essenti
fission
endocyt
vesicl
endocyt
pathway
also
membran
fusion
involv
fusion
pore
expans
addit
dynamin
implic
regul
actin
cytoskeleton
could
account
stronger
neg
effect
dynasor
preincub
cell
ndv
activ
drug
might
neg
affect
endocyt
entri
also
direct
fusion
ndv
cell
plasma
membran
sum
data
regard
effect
dynasor
ndv
fusion
infect
discuss
indic
least
hela
cell
ndv
need
dynamin
activ
describ
virus
hiv
prevent
endosom
acidif
cell
incub
either
concanamycin
inhibitor
vacuolar
h
atpas
monensin
ionophor
disrupt
proton
gradient
across
vesicular
membran
chloroquin
lysosomotrop
agent
increas
ph
insid
endocyt
vesicl
concentr
drug
treatment
time
specifi
tabl
high
toxic
exert
incub
cho
cell
three
drug
experi
perform
hela
cell
line
treatment
interfer
cell
viabil
cell
viabil
higher
data
shown
data
concern
effect
three
differ
compound
ndv
activ
summar
fig
tabl
treatment
cell
one
three
compound
strongli
inhibit
viruscel
fusion
result
approxim
reduct
viruscel
fusion
concanamycin
monensin
treatment
wherea
chloroquin
preincub
reduc
viral
fusion
fig
similarli
three
drug
strongli
reduc
ndv
infect
fig
c
neg
effect
chloroquin
observ
drug
withdrawn
viru
ad
fig
cq
h
ad
h
postinfect
fig
cq
postinfect
mean
neg
effect
would
exert
earli
step
viral
cycl
viral
bind
cell
surfac
unaffect
three
compound
tabl
nevertheless
hela
cell
fusion
infect
inhibit
inhibitor
endosom
acidif
fig
tabl
stronger
enhanc
observ
acidph
treatment
fig
hela
cell
inhibit
viru
infect
result
monensin
treatment
larg
prevent
exposur
acid
ph
supplementari
fig
moreov
concanamycin
monensin
chloroquin
would
interfer
process
ndv
fusion
endosom
compart
addit
rais
endosom
ph
report
chloroquin
multipl
effect
mammalian
cell
chloroquin
inhibit
sarscov
infect
propos
exert
due
interfer
termin
glycosyl
viral
receptor
addit
traffick
event
ndv
entri
might
disturb
sinc
vesicular
atpas
involv
regul
traffick
event
endosom
compart
altern
assay
endocyt
intern
realiz
proteinas
k
protect
experi
detail
materi
method
unintern
virion
well
cell
surfac
glycoprotein
virion
fuse
directli
plasma
membran
would
digest
proteinas
k
contrari
endocytos
virion
becam
protect
digest
cell
signific
proport
hn
glycoprotein
becam
protect
min
incub
fig
correl
use
endocyt
pathway
viru
entri
also
carri
experi
hela
cell
fig
look
hn
protect
min
initi
entri
although
total
digest
viral
glycoprotein
observ
fig
lane
incub
min
detect
increas
proport
nondigest
viral
hn
fig
lane
strongli
support
percentag
viru
would
also
use
endocytosi
enter
cell
line
class
viral
fusion
protein
activ
least
three
differ
trigger
low
ph
receptor
bind
neutral
ph
receptor
bind
follow
low
ph
moreov
fusion
protein
human
metapneumoviru
activ
proteolysi
acid
ph
use
endocyt
pathway
paramyxoviru
entri
suggest
common
entri
mechan
pneumovirina
subfamili
state
ndv
abl
fuse
cell
neutral
ph
nevertheless
shown
hela
cell
fig
enhanc
viral
fusion
infect
approxim
brief
puls
lowph
agreement
previou
data
although
acid
ph
absolut
requir
ndv
infect
acid
ph
environ
would
facilit
conform
chang
need
fusion
decreas
energet
barrier
suggest
hypothet
decreas
would
enough
activ
f
absenc
homotyp
hn
fig
phenotyp
previous
observ
protein
f
mutant
anoth
possibl
acid
ph
would
increas
fusion
promot
activ
hn
protein
mention
second
hn
bind
site
site
ii
activ
upon
receptor
bind
site
exhibit
higher
receptor
avid
site
specul
paramyxoviru
low
ph
may
facilit
exposur
site
ii
thu
increas
fusion
promot
activ
protein
sinc
site
ii
shown
essenti
ndv
f
activ
within
context
vivo
infect
ie
without
lower
ph
experiment
ndv
would
abl
fuse
neutral
acid
ph
depend
entri
pathway
celltypedepend
mechan
certain
percentag
virus
might
endocytos
henc
would
fuse
within
endosom
similarli
virus
util
differ
cellular
entri
pathway
infect
differ
target
cell
herp
simplex
viru
type
enter
cell
plasma
membran
well
lowph
neutralph
endocytosi
depend
cell
line
receptor
also
vaccinia
viru
simultan
use
entri
mechan
cell
type
fusion
plasma
membran
endocytosi
concanamycin
monensin
chloroquin
strongli
inhibit
ndv
fusion
infect
cell
fig
although
fail
observ
effect
inhibitor
bim
fig
increas
ndv
activ
lowph
exposur
cell
line
fig
discrep
may
explain
differ
possibl
ndv
enter
endocytosi
neg
effect
rais
ph
endosom
would
relat
interfer
traffick
event
ndv
entri
discuss
ii
endocyt
entri
ndv
gangliosid
cell
membran
without
gangliosid
cell
may
follow
differ
mechan
hela
cell
contrari
hela
cell
inhibit
viru
infect
result
monensin
treatment
prevent
exposur
acid
ph
supplementari
fig
support
inhibit
endosom
acidif
would
addit
postentri
effect
cell
line
nevertheless
experi
conduct
test
hypothes
cell
line
use
studi
differ
sialoglycoconjug
present
cell
surfac
hela
cell
membran
abund
sialic
acid
compound
comparison
cell
line
data
shown
thu
tempt
specul
differ
might
involv
divers
entri
mechan
ndv
host
cell
viru
engag
proper
molecul
could
endocytos
viral
envelop
would
fuse
endocyt
compart
bind
ndv
sialic
acid
specif
linkag
could
allow
endocyt
entri
ndv
could
directli
requir
either
endocyt
intern
facilit
subsequ
molecular
chang
enabl
endocytosi
experi
need
clarifi
point
data
support
notion
ndv
might
evolv
use
low
ph
endocyt
pathway
enhanc
entri
least
certain
cell
line
addit
direct
fusion
viral
envelop
target
cell
certain
percentag
virus
might
penetr
cell
receptormedi
dynamindepend
endocytosi
entri
versatil
must
taken
consider
order
design
futur
antivir
strategi
supplementari
data
articl
found
onlin
http
dx
